Mechanisms in the pathogenesis of diabetic cardiomyopathy

Mohit Jain, Ronglih Liao, Thomas A. Miller, Nathan K LeBrasseur, Douglas B. Sawyer

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Purpose of review: Diabetes results in the development of diabetic cardiomyopathy, a primary cardiac disease characterized pathologically by cardiomyocyte hypertrophy and apoptosis, and hemodynamically by impaired cardiac relaxation progressing to overt contractile failure. Despite the overwhelming incidence of diabetes, diabetic cardiomyopathy still remains a poorly understood disorder for which no established cause or specific treatment exists. Recent findings: Recent data in animal models of diabetes, as well as studies examining the role of metabolism in regulating myocardial phenotype, suggest that derangements in glucose metabolism and lipid transport may directly alter cardiac structure and function. In this review, we discuss the potential mechanisms underlying the development of diabetic cardiomyopathy. Summary: Recent findings will allow for greater insight into the pathogenesis of diabetic cardiomyopathy and allow for the development of novel therapeutic targets.

Original languageEnglish (US)
Pages (from-to)251-255
Number of pages5
JournalCurrent Opinion in Endocrinology and Diabetes
Volume10
Issue number4
DOIs
StatePublished - Aug 2003
Externally publishedYes

Fingerprint

Diabetic Cardiomyopathies
Lipid Metabolism
Cardiac Myocytes
Hypertrophy
Heart Diseases
Animal Models
Apoptosis
Phenotype
Glucose
Incidence

Keywords

  • Apoptosis
  • Cardiomyocyte hypertrophy
  • Diabetic cardiomyopathy
  • Glucose metabolism
  • PPARα

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Mechanisms in the pathogenesis of diabetic cardiomyopathy. / Jain, Mohit; Liao, Ronglih; Miller, Thomas A.; LeBrasseur, Nathan K; Sawyer, Douglas B.

In: Current Opinion in Endocrinology and Diabetes, Vol. 10, No. 4, 08.2003, p. 251-255.

Research output: Contribution to journalArticle

Jain, Mohit ; Liao, Ronglih ; Miller, Thomas A. ; LeBrasseur, Nathan K ; Sawyer, Douglas B. / Mechanisms in the pathogenesis of diabetic cardiomyopathy. In: Current Opinion in Endocrinology and Diabetes. 2003 ; Vol. 10, No. 4. pp. 251-255.
@article{6b523e6b6e8e46cbb2ff438fae554495,
title = "Mechanisms in the pathogenesis of diabetic cardiomyopathy",
abstract = "Purpose of review: Diabetes results in the development of diabetic cardiomyopathy, a primary cardiac disease characterized pathologically by cardiomyocyte hypertrophy and apoptosis, and hemodynamically by impaired cardiac relaxation progressing to overt contractile failure. Despite the overwhelming incidence of diabetes, diabetic cardiomyopathy still remains a poorly understood disorder for which no established cause or specific treatment exists. Recent findings: Recent data in animal models of diabetes, as well as studies examining the role of metabolism in regulating myocardial phenotype, suggest that derangements in glucose metabolism and lipid transport may directly alter cardiac structure and function. In this review, we discuss the potential mechanisms underlying the development of diabetic cardiomyopathy. Summary: Recent findings will allow for greater insight into the pathogenesis of diabetic cardiomyopathy and allow for the development of novel therapeutic targets.",
keywords = "Apoptosis, Cardiomyocyte hypertrophy, Diabetic cardiomyopathy, Glucose metabolism, PPARα",
author = "Mohit Jain and Ronglih Liao and Miller, {Thomas A.} and LeBrasseur, {Nathan K} and Sawyer, {Douglas B.}",
year = "2003",
month = "8",
doi = "10.1097/00060793-200308000-00004",
language = "English (US)",
volume = "10",
pages = "251--255",
journal = "Current Opinion in Endocrinology, Diabetes and Obesity",
issn = "1752-296X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Mechanisms in the pathogenesis of diabetic cardiomyopathy

AU - Jain, Mohit

AU - Liao, Ronglih

AU - Miller, Thomas A.

AU - LeBrasseur, Nathan K

AU - Sawyer, Douglas B.

PY - 2003/8

Y1 - 2003/8

N2 - Purpose of review: Diabetes results in the development of diabetic cardiomyopathy, a primary cardiac disease characterized pathologically by cardiomyocyte hypertrophy and apoptosis, and hemodynamically by impaired cardiac relaxation progressing to overt contractile failure. Despite the overwhelming incidence of diabetes, diabetic cardiomyopathy still remains a poorly understood disorder for which no established cause or specific treatment exists. Recent findings: Recent data in animal models of diabetes, as well as studies examining the role of metabolism in regulating myocardial phenotype, suggest that derangements in glucose metabolism and lipid transport may directly alter cardiac structure and function. In this review, we discuss the potential mechanisms underlying the development of diabetic cardiomyopathy. Summary: Recent findings will allow for greater insight into the pathogenesis of diabetic cardiomyopathy and allow for the development of novel therapeutic targets.

AB - Purpose of review: Diabetes results in the development of diabetic cardiomyopathy, a primary cardiac disease characterized pathologically by cardiomyocyte hypertrophy and apoptosis, and hemodynamically by impaired cardiac relaxation progressing to overt contractile failure. Despite the overwhelming incidence of diabetes, diabetic cardiomyopathy still remains a poorly understood disorder for which no established cause or specific treatment exists. Recent findings: Recent data in animal models of diabetes, as well as studies examining the role of metabolism in regulating myocardial phenotype, suggest that derangements in glucose metabolism and lipid transport may directly alter cardiac structure and function. In this review, we discuss the potential mechanisms underlying the development of diabetic cardiomyopathy. Summary: Recent findings will allow for greater insight into the pathogenesis of diabetic cardiomyopathy and allow for the development of novel therapeutic targets.

KW - Apoptosis

KW - Cardiomyocyte hypertrophy

KW - Diabetic cardiomyopathy

KW - Glucose metabolism

KW - PPARα

UR - http://www.scopus.com/inward/record.url?scp=0242559049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242559049&partnerID=8YFLogxK

U2 - 10.1097/00060793-200308000-00004

DO - 10.1097/00060793-200308000-00004

M3 - Article

VL - 10

SP - 251

EP - 255

JO - Current Opinion in Endocrinology, Diabetes and Obesity

JF - Current Opinion in Endocrinology, Diabetes and Obesity

SN - 1752-296X

IS - 4

ER -